Compare AUTL & DVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AUTL | DVS |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 431.2M | 446.5M |
| IPO Year | 2025 | N/A |
| Metric | AUTL | DVS |
|---|---|---|
| Price | $1.59 | $4.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 1.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,120,000.00 | N/A |
| Revenue This Year | $669.62 | N/A |
| Revenue Next Year | $79.78 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 496.00 | N/A |
| 52 Week Low | $1.11 | $2.48 |
| 52 Week High | $2.70 | $5.93 |
| Indicator | AUTL | DVS |
|---|---|---|
| Relative Strength Index (RSI) | 50.71 | 45.14 |
| Support Level | $1.27 | $4.28 |
| Resistance Level | $1.74 | $5.04 |
| Average True Range (ATR) | 0.12 | 0.26 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 27.96 | 34.80 |
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
Dolly Varden Silver Corp is a mineral exploration company. The company's primary business is the acquisition, exploration, evaluation, and development of exploration and evaluation assets. It is focused on exploration advancing the Kitsault Valley Project, which includes the Dolly Varden property and the Homestake Ridge property located in the Golden Triangle of British Columbia, Canada.